Home / Leaderboard / Glenview Capital Management, LLC
Glenview Capital Management, LLC
Larry Robbins · Hedge Fund · Long/Short Equity
Glenview Capital Management, LLC is a New York-based investment firm founded in 2000 by Lawrence M. Robbins. The firm is primarily focused on long/short equity strategies, utilizing a fundamental, bottom-up research process to identify companies with strong growth potential and attractive valuations. Glenview has built a reputation for its focus on the healthcare sector and its history of constructive activism in companies like Tenet Healthcare and CVS Health. The firm manages billions of dollars in assets across various fund vehicles, including flagship products and more opportunistic, concentrated portfolios. Throughout its history, Glenview has emphasized a partnership approach with its investors, characterized by deep transparency and a commitment to disciplined, research-intensive investing in stable, predictable businesses.
Simulated Performance
| Metric | Value |
|---|---|
| Total return | +34.1% |
| YTD return | +21.8% |
| Sharpe ratio | 4.25 |
| Win rate | 60% |
| AUM | $4.8B |
| Inception | Oct 1, 2025 |
| Updated | Oct 2, 2026 |
Institution Status
| Field | Value |
|---|---|
| AUM | $4.8B |
| Turnover | Low (<15%) |
| Avg holding | 18 Months |
| Inception | Oct 1, 2025 |
| Website | http://www.glenviewcapital.com/ |
Current Holdings
Updated on Oct 2, 2026.
| Ticker | Name | Portfolio % | Return |
|---|---|---|---|
| GPN | Global Payments Inc | 15.9% | -4.6% |
| THC | Tenet Healthcare Corporation | 12.0% | +22.4% |
| CVS | CVS Health Corp | 8.8% | +8.2% |
| TMO | Thermo Fisher Scientific Inc | 8.8% | +15.3% |
| A | Agilent Technologies Inc | 7.1% | +9.1% |
| AMZN | Amazon.com Inc | 6.6% | +6.9% |
| META | Meta Platforms Inc. | 5.6% | +22.8% |
| DHR | Danaher Corporation | 5.3% | -0.9% |
| TEVA | Teva Pharma Industries Ltd ADR | 4.1% | +68.4% |
| AMD | Advanced Micro Devices Inc | 3.9% | +59.7% |
| VTRS | Viatris Inc | 3.6% | +41.3% |
| UBER | Uber Technologies Inc | 2.6% | -5.6% |
| CNC | Centene Corp | 2.5% | +9.7% |
| BFLY | Butterfly Network Inc | 2.3% | +82.1% |
| CI | Cigna Corp | 2.3% | -5.5% |
| HUM | Humana Inc | 2.2% | +21.0% |
| XYZ | Block, Inc | 1.9% | +6.6% |
| GENI | Genius Sports Ltd | 1.8% | +0.1% |
| LLY | Eli Lilly and Company | 1.4% | -2.6% |
| ONTO | Onto Innovation Inc | 1.2% | +14.0% |
Recent activity
| Date | Action | Ticker | Weight |
|---|---|---|---|
| Sep 28, 2026 | BUY | HUM | 2.1% → 2.2% |
| Sep 28, 2026 | SELL | TMO | 8.8% → 8.8% |
| Sep 28, 2026 | SELL | THC | 12.5% → 12.0% |
| Sep 28, 2026 | SELL | UAL | 1.2% → 0.0% |
| Sep 28, 2026 | SELL | A | 6.6% → 7.1% |
Investment Style Analysis
Glenview Capital Management, LLC is widely recognized for employing a Long/Short Equity strategy. As of Oct 2, 2026, the firm oversees approximately $4.8B in assets under management (AUM). The portfolio demonstrates a clear preference for the Diagnostics & Research and Specialty Business Services sectors, reflecting a high-conviction approach to capital allocation.
Recent Market Moves
During the latest rebalancing period ending Sep 28, Glenview Capital Management, LLC made a significant move by increasing exposure to HUM. This adjustment aligns with the fund's dynamic approach to risk management and capital deployment in current market conditions.
Investment Philosophy
Glenview Capital Management employs a fundamental, research-driven investment process focused on a bottom-up approach to security selection. The firm’s core philosophy is centered on identifying businesses that possess known and knowable fundamental characteristics, the ability to compound value over time, and securities trading at attractive prices relative to earnings and free cash flow. This strategy, often termed growth at a reasonable price (GARP), prioritizes stable and predictable industries with recurring revenues. While primarily a long/short equity manager, Glenview also adopts contrarian views and engages in opportunistic investments, sometimes utilizing shareholder activism to drive corporate changes and unlock value. The firm maintains a long-term investment horizon, typically one to three years, and focuses on high-conviction, concentrated positions to maximize risk-adjusted returns.
Disclaimer
The content provided on this page, including the simulated portfolio performance, holdings analysis, and AI-generated insights, is for informational and educational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. All data is derived from historical SEC 13F filings and other public disclosures, which have a reporting lag. The "Simulated Performance" is a hypothetical reconstruction based on past disclosures and does not represent the actual returns of the institution. Past performance is not indicative of future results. Tritonix.ai is not affiliated with Glenview Capital Management, LLC.
Similar Investment Style
Based on Long/Short Equity.
- Perceptive Advisors LLC — Joseph Edelman · 3M -7.5%
- Zweig-DiMenna Associates, Inc. — Joseph DiMenna · 3M +6.8%
- Redmile Group, LLC — Jeremy Green · 3M -16.4%
- FengHe Fund Management Pte. Ltd. — John Wu · 3M -3.4%
Frequently asked questions
How is the simulated portfolio for Glenview Capital Management, LLC constructed?
This simulation is powered by Tritonix AI using official SEC filings. We focus on the "Best Ideas" by filtering for only the Top 20 largest holdings and rebalancing them to 100%. The simulation tracks performance starting from Oct 1, 2025. Our AI monitors for updates every Monday to capture major shifts. This concentrated approach highlights the manager's true stock-picking skill and mirrors their actual investment returns.
What is Glenview Capital Management, LLC's largest holding?
As of the latest filing, Glenview Capital Management, LLC's top position is Global Payments Inc (GPN), representing 15.9% of the portfolio. This reflects a high-conviction bet by the institution.
What is Glenview Capital Management, LLC's historical performance and risk profile?
Our simulation indicates a total return of +34.1% with a win rate of 60%. Notably, the portfolio maintains a Sharpe Ratio of 4.25, suggesting an exceptional level of risk-adjusted returns compared to the broader market.
What sectors does Glenview Capital Management, LLC primarily invest in?
Glenview Capital Management, LLC has a strong preference for the Diagnostics & Research sector, which makes up 21.2% of their disclosed assets. The portfolio also has exposure to Specialty Business Services, indicating a specific thematic focus.
Is Glenview Capital Management, LLC's portfolio concentrated or diversified?
Glenview Capital Management, LLC runs a moderately concentrated portfolio with 20 disclosed positions. The top 3 holdings alone account for 36.8% of the total portfolio weight, suggesting a strategy that favors broader market exposure.
How has Glenview Capital Management, LLC performed in 2026?
Our AI-simulated model portfolio for Glenview Capital Management, LLC tracks a Year-to-Date (YTD) return of +21.8%. This metric helps investors gauge the institution's effectiveness in the current market environment.
Does Larry Robbins manage Glenview Capital Management, LLC directly?
Yes, Larry Robbins serves as the key portfolio manager for Glenview Capital Management, LLC, overseeing the investment strategy and final capital allocation decisions.